# Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

> **NCT00352677** · PHASE1 · COMPLETED · sponsor: **CytRx** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia
- Acute Lymphocytic Leukemia

## Interventions

- **DRUG:** INNO-406

## Key facts

- **NCT ID:** NCT00352677
- **Lead sponsor:** CytRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352677, "Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00352677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*